Registry for autoimmune and cholestatic liver diseases in Spain

Registro Español de Enfermedades Hepáticas Colestásicas y Autoinmunes (ColHai)

Observational Asociación Española para el Estudio del Hígado · NCT06767605

This study is collecting information from patients with liver diseases in Spain to better understand these conditions and improve care for those affected.

Quick facts

Study typeObservational
Enrollment5000 (estimated)
Ages18 Years and up
SexAll
SponsorAsociación Española para el Estudio del Hígado Academic / other
Locations1 site (Barcelona)
Trial IDNCT06767605 on ClinicalTrials.gov

What this trial studies

This registry aims to gather comprehensive data on patients diagnosed with primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, and genetic cholestatic diseases in Spain. By collecting and analyzing patient information, the registry seeks to enhance understanding of these conditions and improve patient care. The observational nature of the study allows for real-world data collection without any specific interventions.

Who should consider this trial

Good fit: Ideal candidates for this registry are patients with a confirmed diagnosis of primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, or genetic cholestatic diseases.

Not a fit: Patients who refuse to sign the informed consent for participation will not benefit from this registry.

Why it matters

Potential benefit: If successful, this registry could lead to improved diagnosis, treatment strategies, and management of autoimmune and cholestatic liver diseases.

How similar studies have performed: While this registry approach is common, the specific focus on these liver diseases in Spain may provide novel insights that have not been extensively studied before.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease

Exclusion Criteria:

* Refusal to sign the informed consent for the study

Where this trial is running

Barcelona

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Hepatitis Autoimmune DiseasePrimary Biliary CholangitisPrimary Sclerosing CholangitisCholestatic Genetic DiseasesPFIC tipo 1PFIC tipo 2PFIC tipo 3PFIC tipo 4
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.